Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

With the rise in the popularity of weight loss drugs like ‘Wegovy’ and ‘Ozempic,’ we’re learning a counterfeit market has ...

The drug is used to treat type 2 diabetes and obesity and it works by mimicking the effects of the body’s natural hormone, ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

These naturally occurring hormones play crucial roles in regulating insulin ... marked doses on the pens (0.25, 0.5, 1.0 and ...

Novo Nordisk NVO is expected to beat estimates when it reports third-quarter 2024 results on Nov. 6, before the opening bell.

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

The price of insulin has been a major flashpoint in the conversation around rising U.S. healthcare costs. Individual stories ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

2 In July this year Novo Nordisk was again reprimanded after it admitted failing to disclose around £7.8m in payments to 150 recipients, including doctors, patients, journalists, and healthcare ...

The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has promoted its weight loss medications semaglutide (Ozempic/Wegovy) and ...